Bright Peak Therapeutics
Matilde Arevalo Ruiz has a wealth of experience in the scientific field. Matilde began their career in 2008 as an alumna interna at the University of Granada. Matilde then moved on to a predoctoral estancia at CSIC in 2012. In 2013, they became a becaria FPU at CSIC. In 2017, they took on the role of Doctor at IPBLN (CSIC). In 2018, they became an Investigador posdoctoral at ETH Zürich. Finally, in 2019, they accepted the position of Scientist at both Bright Peak Therapeutics and Bright Peak Therapeutics AG.
Matilde Arevalo Ruiz completed their Licenciatura en Farmacia from Universidad de Granada between 2005 and 2010, specializing in Master Biotecnología.
This person is not in any offices
Bright Peak Therapeutics
1 followers
Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases.